+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global ENT Disorder Treatment Market by Treatment Type (Device, Drugs), Disorder Type (Ear, Nose, Throat), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967902
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The ENT Disorder Treatment Market grew from USD 25.34 billion in 2023 to USD 26.83 billion in 2024. It is expected to continue growing at a CAGR of 6.26%, reaching USD 38.77 billion by 2030.

These disorders can range from common issues, such as sinus infections and hearing loss, to more complex conditions, like throat cancer or cranial nerve disorders. The treatment is vital for alleviating symptoms, improving quality of life, and preventing complications leading to more severe health risks. The rising prevalence of allergic reactions and respiratory ailments due to pollution has boosted the demand for ENT disorder treatment. In addition, the growing aging population worldwide is more prone to chronic ENT disorders, such as hearing loss and sinusitis. This demographic shift is driving the demand for enhanced ENT treatment solutions to cater to the unique needs of elderly patients. However, the strict regulations associated with ENT drugs and medicine and their lengthy approvals present a significant challenge for the key players. Companies frequently work towards introducing a novel treatment option to remain agile within the landscape. Moreover, technological innovations in medical devices and treatment methods have greatly enhanced the efficacy and efficiency of ENT treatments. Innovations such as minimally invasive surgery and laser treatments have expanded patient treatment options, contributing to market growth.

Regional Insights

In the Americas, an increasing prevalence of ENT disorders and a robust healthcare infrastructure spurs significant market growth. High consumer awareness and willingness to invest in advanced treatments, including minimally invasive surgeries, drive innovation in this region. Recent patents emphasize novel diagnostic tools and targeted therapies. The region’s public and private sector investments fuel research initiatives, notably in biologics and precision medicine. On the other hand, EMEA demonstrates a strong commitment to research and innovation in ENT treatments, buoyed by its well-established healthcare systems. Cross-border collaborations for clinical trials and R&D are common in the region, paving the way for novel therapies and devices. Regulatory support further facilitates market access for new solutions, catering to a diverse patient population. The Asia Pacific region is witnessing significant growth in the ENT disorder treatment market, driven by rising incidences of ENT-related diseases, an aging population, and improvements in healthcare infrastructure. Countries such as China and India, with their large populations, are seeing an increase in the demand for ENT treatments due to factors including pollution, poor lifestyle choices, and genetic conditions. The presence of significant pharmaceutical companies and emerging local players in the region investing heavily in R&D for more effective and affordable treatments is also propelling the market forward.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the ENT Disorder Treatment Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • The rising prevalence of ear, nose, and throat allergens among individuals
  • The growing aging population worldwide and the need of invasive care for chronic ENT disorders and hearing loss
  • Owing adoption of digital and home-based ENT diagnosis

Market Restraints

  • Strict regulations associated with the approval of ENT drugs and devices

Market Opportunities

  • Technological advancements in the diagnostic and treatment procedures of ENT disorder
  • Favorable government initiatives and funding for ENT-related diseases

Market Challenges

  • Insufficient awareness about ENT disorders and available treatments in underdeveloped regions

Market Segmentation Analysis

  • Treatment Type: Utilization of ENT devices and ENT medications to cater severe ENT conditions
  • End-User: Increasing usage of ENT devices in hospitals & ambulatory surgical centers offering specialized care while delivering high-quality care

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the ENT Disorder Treatment Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the ENT Disorder Treatment Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Integra (IART) to Advance ENT Division with New Buyout Deal

Integra Lifesciences Corporation (IART) has entered into a definitive agreement to acquire Acclarent in a USD 275 million cash transaction. This acquisition signifies a critical expansion for Integra, including an additional commitment of USD 5 million tied to achieving certain regulatory milestones. This step marks a significant milestone for Integra, aiming to bolster its position in the ENT market by integrating Acclarent's innovative solutions into its offering.

Fifth Sense and ENT UK Announce Strategic Partnership to Improve Care for People Affected by Smell and Taste Disorders

Fifth Sense partnered with ENT UK to advance the management of smell and taste disorders. This partnership signifies a united commitment to enhancing the support network for individuals and families grappling with these conditions, prominently including directing them to the invaluable resources offered by the Fifth Sense Support and Information Service. This initiative represents a significant step forward in addressing the challenges those affected by smell and taste disorders face, ensuring they receive the comprehensive care and support they require.

Oto and Lindus Health Launch a Remote Trial to Increase Patient Access to Tinnitus Therapy

Digital healthcare company Oto, in partnership with clinical trial innovator Lindus Health, launched an entirely remote clinical trial aimed at enhancing accessibility to transformative therapy for individuals battling tinnitus. Oto leverages a sophisticated digital platform to offer an evidence-backed cognitive behavioral therapy (CBT) program meticulously designed by tinnitus experts.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the ENT Disorder Treatment Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the ENT Disorder Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., ALK-Abelló AS, Apikos Pharma, AstraZeneca PLC, Bayer AG, Cipla Limited, Covis Pharma BV, Dr. Reddy's Laboratories, F. Hoffmann-La Roche AG, Fennec Pharmaceuticals Inc., GlaxoSmithKline PLC, Integra Lifesciences Corporation, Integra Lifesciences CorporationAbbVie Inc., Intersect ENT, Inc. by Medtronic PLC, Johnson & Johnson Services, Inc., Karl Storz, Merck & Co., Inc., Novartis AG, Olympus Corporation, OptiNose US, Inc., Pfizer Inc., Sanofi SA, Sensorion SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Vitaris Inc..

Market Segmentation & Coverage

This research report categorizes the ENT Disorder Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment Type- Device

  • Cochlear Implants
  • Continuous Positive Airway Pressure Devices
  • Hearing Aids
  • Nasal Splints

Drugs

  • Anti-inflammatory Drugs
  • Antibiotics
  • Antihistamines
  • Steroids
  • Disorder Type

Ear

  • Meniere's Disease
  • Otitis Externa
  • Otitis Media
  • Otomycosis

Nose

  • Nasal Polyps
  • Rhinitis
  • Sinusitis

Throat

  • Pharyngitis
  • Tonsillitis
  • Tonsillopharyngitis

End-User

  • Ambulatory Surgical Centers
  • ENT Clinics
  • Hospitals
  • Specialty Clinics

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. The rising prevalence of ear, nose, and throat allergens among individuals
5.1.1.2. The growing aging population worldwide and the need of invasive care for chronic ENT disorders and hearing loss
5.1.1.3. Owing adoption of digital and home-based ENT diagnosis
5.1.2. Restraints
5.1.2.1. Strict regulations associated with the approval of ENT drugs and devices
5.1.3. Opportunities
5.1.3.1. Technological advancements in the diagnostic and treatment procedures of ENT disorder
5.1.3.2. Favorable government initiatives and funding for ENT-related diseases
5.1.4. Challenges
5.1.4.1. Insufficient awareness about ENT disorders and available treatments in underdeveloped regions
5.2. Market Segmentation Analysis
5.2.1. Treatment Type: Utilization of ENT devices and ENT medications to cater severe ENT conditions
5.2.2. End-User: Increasing usage of ENT devices in hospitals & ambulatory surgical centers offering specialized care while delivering high-quality care
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. ENT Disorder Treatment Market, by Treatment Type
6.1. Introduction
6.2. Device
6.3. Drugs
7. ENT Disorder Treatment Market, by Disorder Type
7.1. Introduction
7.2. Ear
7.3. Nose
7.4. Throat
8. ENT Disorder Treatment Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. ENT Clinics
8.4. Hospitals
8.5. Specialty Clinics
9. Americas ENT Disorder Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific ENT Disorder Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa ENT Disorder Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Integra (IART) to Advance ENT Division with New Buyout Deal
12.3.2. Fifth Sense and ENT UK Announce Strategic Partnership to Improve Care for People Affected by Smell and Taste Disorders
12.3.3. Oto and Lindus Health Launch a Remote Trial to Increase Patient Access to Tinnitus Therapy
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. ENT DISORDER TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. ENT DISORDER TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ENT DISORDER TREATMENT MARKET DYNAMICS
FIGURE 7. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ENT DISORDER TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. ENT DISORDER TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ENT DISORDER TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY COCHLEAR IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HEARING AIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HEARING AIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL SPLINTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL SPLINTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTI-INFLAMMATORY DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY STEROIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY STEROIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY MENIERE'S DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY MENIERE'S DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS EXTERNA, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS EXTERNA, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTITIS MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTOMYCOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY OTOMYCOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL POLYPS, BY REGION, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY NASAL POLYPS, BY REGION, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY RHINITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY RHINITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SINUSITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SINUSITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY PHARYNGITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY PHARYNGITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLOPHARYNGITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY TONSILLOPHARYNGITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ENT CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY ENT CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL ENT DISORDER TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 83. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 84. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 85. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 86. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 91. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 92. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 93. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 94. AMERICAS ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 97. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 98. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 99. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 100. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 101. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 102. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 103. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 104. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 105. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 106. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 107. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 108. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 109. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 110. ARGENTINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 111. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 112. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 113. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 114. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 115. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 116. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 117. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 118. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 119. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 120. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 121. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 122. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 123. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 124. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 125. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 126. BRAZIL ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 127. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 128. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 129. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 130. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 131. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 132. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 133. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 134. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 135. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 136. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 137. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 138. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 139. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 140. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 141. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. CANADA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 144. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 145. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 146. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 147. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 148. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 149. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 150. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 151. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 152. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 153. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 154. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 155. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 156. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 157. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 158. MEXICO ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 159. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 160. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 161. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 162. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 163. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 164. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 165. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 166. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 167. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 168. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 169. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 170. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 171. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 172. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 173. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 176. UNITED STATES ENT DISORDER TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 178. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 179. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 180. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 182. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 184. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 186. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 188. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 190. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 194. ASIA-PACIFIC ENT DISORDER TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 195. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 196. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 197. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 198. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 199. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 200. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 201. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 202. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 203. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 204. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 205. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 206. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 207. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 208. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 209. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. AUSTRALIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 212. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 213. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 214. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 215. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 216. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 217. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 218. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 219. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 220. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 221. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 222. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 223. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 224. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 225. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 226. CHINA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 227. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 228. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 229. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 230. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 231. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 232. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 233. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 234. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 235. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 236. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 237. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 238. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 239. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 240. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 241. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 242. INDIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 243. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 244. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 245. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 246. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 247. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 248. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 249. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 250. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 251. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 252. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 253. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 254. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 255. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 256. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 257. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. INDONESIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 260. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 261. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 262. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 263. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 264. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 265. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 266. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 267. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 268. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 269. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 270. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 271. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 272. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 273. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 274. JAPAN ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 275. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 276. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 277. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 278. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 279. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 280. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 281. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 282. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 283. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 284. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 285. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 286. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 287. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 288. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 289. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 290. MALAYSIA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 291. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 292. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 293. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 294. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 295. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 296. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 297. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 298. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 299. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 300. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 301. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 302. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 303. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 304. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 305. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 306. PHILIPPINES ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 307. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 308. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 309. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 310. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 311. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 312. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 313. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 314. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 315. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 316. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 317. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 318. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 319. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 320. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 321. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. SINGAPORE ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 324. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 325. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 326. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 327. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 328. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 329. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 330. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 331. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 332. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
TABLE 333. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2018-2023 (USD MILLION)
TABLE 334. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY NOSE, 2024-2030 (USD MILLION)
TABLE 335. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2018-2023 (USD MILLION)
TABLE 336. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY THROAT, 2024-2030 (USD MILLION)
TABLE 337. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 338. SOUTH KOREA ENT DISORDER TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 339. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2023 (USD MILLION)
TABLE 340. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024-2030 (USD MILLION)
TABLE 341. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2018-2023 (USD MILLION)
TABLE 342. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DEVICE, 2024-2030 (USD MILLION)
TABLE 343. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
TABLE 344. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
TABLE 345. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2018-2023 (USD MILLION)
TABLE 346. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY DISORDER TYPE, 2024-2030 (USD MILLION)
TABLE 347. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2018-2023 (USD MILLION)
TABLE 348. TAIWAN ENT DISORDER TREATMENT MARKET SIZE, BY EAR, 2024-2030 (USD MILLION)
T

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • ALK-Abelló AS
  • Apikos Pharma
  • AstraZeneca PLC
  • Bayer AG
  • Cipla Limited
  • Covis Pharma BV
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche AG
  • Fennec Pharmaceuticals Inc.
  • GlaxoSmithKline PLC
  • Integra Lifesciences Corporation
  • Integra Lifesciences CorporationAbbVie Inc.
  • Intersect ENT, Inc. by Medtronic PLC
  • Johnson & Johnson Services, Inc.
  • Karl Storz
  • Merck & Co., Inc.
  • Novartis AG
  • Olympus Corporation
  • OptiNose US, Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Sensorion SA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Vitaris Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 26.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 38.77 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal

Related Topics

Related Reports

ENT Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

ENT Disorder Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 91 Pages
  • Global
From
Global Pediatric Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Global Pediatric Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 119 Pages
  • Global
From
Rare Diseases Treatment Global Market Report 2024 - Product Image

Rare Diseases Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Down Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034? - Product Image

Down Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

  • Report
  • 137 Pages
  • Global
From
Pediatric Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Pediatric Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From

About the ENT Disorder Drug Market

The ENT Disorder Drug market is a segment of the pharmaceutical industry that focuses on drugs used to treat diseases and disorders of the ear, nose, and throat. These drugs are used to treat a variety of conditions, including allergies, sinusitis, hearing loss, and sleep apnea. Common treatments include antihistamines, decongestants, antibiotics, and steroids. ENT Disorder Drugs are also used to treat conditions such as vertigo, tinnitus, and laryngitis. The ENT Disorder Drug market is highly competitive, with many companies offering a wide range of products. Major players in the market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Sanofi. Other companies in the market include AstraZeneca, Bayer, Johnson & Johnson, and Eli Lilly. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.